Résultats de la recherche - 84 results
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...
Differences in primary palliative care between people with organ failure and people with cancer: An international mortality follow-back study using quality indicators.
fewest (two out of nine indicators). CONCLUSION: People who died of organ failure are at risk of receiving lower quality palliative care than people who died of cancer, but the differences vary per ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
assays are foreseen to be evaluated: RealTime High Risk HPV assay (Abbott), cobas-4800 and-6800 (Roche), Onclarity (BD), Xpert HPV (Cepheid) and Anyplex II HPV HR (Seegene). CONCLUSION: Given empirical ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
assessment, we considered it as high-risk (hr) HPV positive when at least one of the following HPV types was present: HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, and ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
performance of various HPV tests relative to the validated and accepted comparator test in a formalized and uniform manner. The aim of this study was to evaluate the clinical performance of the HPV-Risk assay ...
Defining optimal triage strategies for hrHPV screen positive women- an evaluation of HPV 16/18 genotyping, cytology and p16/Ki-67 cyto-immunochemistry.
Lynne; Govan, Lynn; Black, Janice; Palmer, Tim; M. Arbyn Source: Cancer Epidemiol Biomarkers Prev (2017) Abstract: BACKGROUND: Several options for the triage of high-risk HPV screen positive (hrHPV+) women ...
Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University Hospital.
with a lower risk of obstetrical harms on a subsequent pregnancy. STUDY DESIGN: A retrospective matched cohort study was performed in a tertiary referral unit in Belgium. A total of 97 women were ...
Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis.
significant (p>0.05). For patients aged 11.82 years (population mean age), poor body mass index had the greatest impact on FEV1 in 2008, followed by high-risk genotype (two severe mutations), female gender, ...
Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
Aged Cyclin-Dependent Kinase Inhibitor p16 Female Head and Neck Neoplasms Humans India Male middle aged Papillomaviridae Papillomavirus Infections Abstract: Mucosal high-risk (HR) human papillomaviruses ...